Our literature review highlights the potential of both established and emerging biomarkers for diagnosing NEC, including TGF-β1, IL-33, L-FABP, SAA, Calgranulin-C, volatile organic compounds (VOCs), Gal-4, and others. This evidence concerns the gene FABP1 and necrotizing enterocolitis.